Atomo Diagnostics Ltd (Atomo) is a medical device company that designs, develops, manufactures and commercializes in-vitro diagnostic products. The company's products include HIV self-test products, HIV professional use test products and pregnancy test products among others. Its products are used for self-test consumer applications for detecting infectious diseases, measuring markers and hormone levels, and screening for chronic conditions. The company develops its products using the OEM device platform. It also offers custom devices. The company has operations in South Africa, the UK and Australia. Atomo is headquartered in Sydney, New South Wales, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Atomo Diagnostics Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Atomo Diagnostics Ltd Company Overview
Atomo Diagnostics Ltd Company Snapshot
Atomo Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
AtomoRapid COVID-19 (IgG/IgM) Test Product Overview
AtomoRapid HIV
AtomoRapid HIV Product Overview
DaVinci Combo Self Test
DaVinci Combo Self Test Product Overview
Diagnostic Test - HCV
Diagnostic Test - HCV Product Overview
Rapid COVID-19 Self Test
Rapid COVID-19 Self Test Product Overview
Rapid Diagnostic Test - COVID-19
Rapid Diagnostic Test - COVID-19 Product Overview
Atomo Diagnostics Ltd - Key Competitors
Atomo Diagnostics Ltd - Key Employees
Atomo Diagnostics Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Atomo Diagnostics Ltd, Recent Developments
Nov 13, 2024: Atomo Secures Australian Order for Supply of HIV Self-Tests
Jun 12, 2024: Procurement of Atomo HIV Self-Tests commencing through public health funding
Apr 15, 2024: Atomo secures significant order for HIV Self-Tests for LMIC Territories
Dec 09, 2023: Atomo and BBI enter into Collaboration Agreement
Jun 14, 2023: Atomo and Newfoundland Sign Agreement for HIV Testing in Europe
Feb 28, 2023: Significant purchase order for HIV self-tests for Europe
Jan 18, 2023: Atomo and NG Biotech sign new commercialisation agreement to expand the launch of a unique blood based rapid pregnancy test in key global markets
Feb 07, 2022: Owen Mumford announces partnerships with leading charities during HIV testing week
Jan 27, 2022: Atomo receives approval for its COVID-19 antigen test in NZ
Oct 26, 2021: Atomo HIV Self-Test – improved supply and advertising conditions in Australia
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Atomo Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
Atomo Diagnostics Ltd Pipeline Products by Equipment Type
Atomo Diagnostics Ltd Pipeline Products by Indication
Atomo Diagnostics Ltd, Key Facts
Atomo Diagnostics Ltd, Major Products and Services
Atomo Diagnostics Ltd Number of Pipeline Products by Development Stage
Atomo Diagnostics Ltd Pipeline Products Summary by Development Stage
Atomo Blackburn Swab Device - Product Status
Atomo Blackburn Swab Device - Product Description
Atomo Swab Based Rapid Test Device - Product Status
Atomo Swab Based Rapid Test Device - Product Description
AtomoRapid - Allergy - Product Status
AtomoRapid - Allergy - Product Description
AtomoRapid - Celiac Disease - Product Status
AtomoRapid - Celiac Disease - Product Description
AtomoRapid - Chikungunya - Product Status
AtomoRapid - Chikungunya - Product Description
AtomoRapid - Coagulation Monitoring - Product Status